Immunome Inc

NASDAQ:IMNM   3:59:51 PM EDT
3.23
-0.12 (-3.58%)
Earnings Announcements

Immunome Reports First Quarter 2022 Financial Results

Published: 05/12/2022 12:34 GMT
Immunome Inc (IMNM) - Immunome Reports First Quarter 2022 Financial Results.
Qtrly Loss per Share $0.96.
As of March 31, 2022, Cash and Cash Equivalents Totaled $42.9 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.75

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.82

More details on our Analysts Page.